Home › Johnson & Johnson, ViaCyte testing possible diabetes cure
 

Keywords :   


Johnson & Johnson, ViaCyte testing possible diabetes cure

2016-02-04 07:46:33| Biotech - Topix.net

Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix the life-threatening hormonal disorder. They've already begun testing it in a small number of diabetic patients.

Tags: testing johnson cure diabetes

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.05Melting Massage Bar Patented by Johnson & Johnson
03.05How the computer games industry is embracing AI
03.05Apple sees biggest fall in sales for a year
02.05Turkey halts trade with Israel over Gaza 'tragedy'
02.05Loop Industries and Ester Ltd. Announce Joint Venture
02.05The Oldham Group names Hunter Collins account manager
02.05NCBAs Sigrid Johannes promoted to Senior Director of Government Affairs
02.05University helps neighboring ranchers oust redcedars
More »